[OPTIMIZATION OF GLUCOSE METABOLISM IN PATIENTS UNDERGOING THERAPEUTIC HYPOTHERMIA AFTER SUDDEN CARDIAC ARREST]

Revista De Enfermeria (Barcelona, Spain)
|December 22, 2015
PubMed

Insights

Therapeutic hypothermia (TH) for sudden cardiac arrest (SCA) survivors showed improved glycemic control with a specific insulin protocol. This approach reduced blood glucose alterations during TH stages, with low hypoglycemia rates.

Area of Science:

  • Cardiology
  • Intensive Care Medicine
  • Endocrinology

Context:

  • Therapeutic hypothermia (TH) is a critical intervention for sudden cardiac arrest (SCA) survivors.
  • Glycemic control in patients undergoing TH is not well-established.
  • This study investigates glycemic management during TH.

Purpose:

  • To evaluate the effectiveness of a specific insulin protocol for glycemic control in SCA survivors treated with TH.
  • To analyze glycemic levels across different stages of TH (induction, maintenance, rewarming).

Summary:

  • A retrospective analysis of 49 SCA survivors treated with TH and a specific insulin protocol was conducted.
  • High rates of glycemic alteration were observed during the induction stage, decreasing significantly by the rewarming stage (95.9% to 69.4%).
  • The protocol resulted in low rates of severe hypoglycemia (12%), in-hospital mortality (20%), and anoxic encephalopathy (27%).

Impact:

  • The findings suggest that a dedicated insulin protocol can improve blood glucose management in patients undergoing TH.
  • Further research is warranted to confirm the clinical impact of such protocols on patient outcomes.
  • This study provides valuable insights for optimizing care protocols in post-SCA management.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
1.3K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.3K
Decreased Body Temperature01:29

Decreased Body Temperature

A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
1.2K
Metabolic States of the Body: The Postabsorptive State01:18

Metabolic States of the Body: The Postabsorptive State

The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
1.6K